Veracyte | VCYT - 债务利息支出

股票价格

34.33

每天变化

1.18 3.56%

每月一次

4.70%

每年

6.52%

Q2 预测

33.60

金融业

USD

USD 1.41B

现金及等价物

USD 362.58M

USD 39.29M

USD 488.38M

USD 59.94M

USD 40.45M

USD 24.63M

USD 42.31M

824

EPS每股收益

USD 0.53

股本和储备

USD 1.26B

USD 101.97M

债务利息支出

USD 2K

USD 3.48M

USD 0

USD 2.6B

USD 41.15M

USD 116.01M

USD 24.63M

普通股股本

USD 79.05M

45.3

USD 40.63M

USD 140.6M

销售和管理费用

USD 43.31M

USD 20.55M

贸易债权人

USD 4.59M

应收帐款人

USD 44.66M

	债务利息支出	更改		日
Agenus	USD 16.02M		2.85M	2025-12
Agilent	USD 25M		2M	2025-12
Anika Therapeutics	189.44M		1.76M	2025-09
Arrowhead Research	USD 22.5M		811K	2025-12
Bruker	USD 20M		4.3M	2025-09
Heron Therapeutics	USD 600K		100K	2024-12
Illumina	USD 25M		0	2025-09
Intrexon	USD 2K		5K	2024-06
Karyopharm Therapeutics	USD 12.62M		1.24M	2025-12
Laboratory Of America	USD 55M		1000K	2025-12
Ligand Pharmaceuticals	USD 910K		243K	2025-09
Myriad Genetics	USD 4.4M		600K	2025-12
Rigel Pharmaceuticals	USD 2.06M		31K	2024-09
Roche Holding	CHF 304M		7.5M	2025-06
Sangamo BioSciences	97.56M		11.39M	2025-06
Siemens	EUR 435M		1000K	2025-12
Sonic Healthcare	AUD 86.91M		43.94M	2024-12
Thermo Fisher Scientific	USD 354M		11M	2026-03
Veracyte	USD 2K		1000	2023-12
Waters	USD 8.62M		18.02M	2025-12